Stay updated on AXA4010 Safety in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.

Latest updates to the AXA4010 Safety in Sickle Cell Disease Clinical Trial page
- Check3 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe displayed site revision changed from v3.7.0 to v3.7.1 on an otherwise unchanged 403 Forbidden page.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now loads a 403 Forbidden error, replacing the study record with an access-denied message. As a result, the essential trial details, locations, and related content are no longer viewable from that URL.SummaryDifference17%

- Check38 days agoChange DetectedFooter revision updated from v3.6.6 to v3.7.0, indicating a new version of the page. This update reflects a backend/content management change rather than any modification to the study data or eligibility criteria.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision label has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to AXA4010 Safety in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXA4010 Safety in Sickle Cell Disease Clinical Trial page.